tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Simos Simeonidis, 46 are a BUY (77.97%), 10 are a HOLD (16.95%), 3 are a SELL (5.08%).
Analyst Simos Simeonidis, carries an average stock price target met ratio of 73.64% that have a potential upside of 47.09% achieved within 634 days. Previously, Simos Simeonidis worked at RBC.
Simos Simeonidis’s has documented 106 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 28-Apr-2017.
Analyst best performing recommendations are on DVAX (DYNAVAX TECHNOLOGIES).
The best stock recommendation documented was for DVAX (DYNAVAX TECHNOLOGIES) at 4/27/2016. The price target of $17 was fulfilled within 2 days with a profit of $1.53 (8.26%) receiving and performance score of 41.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 5 months ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 5 months 2 days ago
(03-May-2021)
17/29 (58.62%)
$2.73 (1.60%)
650
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 5 months 9 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 8 months 1 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
5 years 8 months 1 days ago
(04-Feb-2021)
32/33 (96.97%)
$10.41 (6.69%)
867
